New Insights into Glioblastoma.

Glioblastoma (GBM) is a highly aggressive brain tumor with a low survival rate. Current treatment strategies have limited success, and novel therapies are needed. This article discusses various approaches to treating GBM, including targeting sphingolipids, using ultrasound waves to open the blood-brain barrier, exploring immunotherapy options, and identifying molecular alterations for targeted therapies. Ongoing clinical trials and interdisciplinary research are crucial for improving GBM treatment and patient outcomes. [Extracted from the article]

Copyright of International Journal of Molecular Sciences is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)